Abstract It is well established that ATP is co-secreted with insulin and zinc from pancreatic beta-cells (β-cells) in response to elevations in extracellular glucose concentration. Despite this knowledge, the physiological roles of extracellular secreted ATP and zinc are ill-defined. We hypothesized that secreted ATP and zinc are autocrine purinergic signaling molecules that activate P2X purinergic receptor (P2XR) channels expressed by β-cells to enhance glucose-stimulated insulin secretion (GSIS). To test this postulate, we performed ELISA assays for secreted insulin at fixed time points within a "real-time" assay and confirmed that the physiological insulin secretagogue glucose stimulates secretion of ATP and zinc into the extracellular milieu along with insulin from primary rat islets. Exogenous ATP and zinc alone or together also induced insulin secretion in this model system. Most importantly, the presence of an extracellular ATP scavenger, a zinc chelator, and P2 receptor antagonists attenuated GSIS. Furthermore, mRNA and protein were expressed in immortalized β-cells and primary islets for a unique subset of P2XR channel subtypes, P2X 2 , P2X 3 , P2X 4 , and P2X 6 , which are each gated by extracellular ATP and modulated positively by extracellular zinc. On the basis of these results, we propose that, within endocrine pancreatic islets, secreted ATP and zinc have profound autocrine regulatory influence on insulin secretion via ATP-gated and zincmodulated P2XR channels.
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Introduction
Glucose is a prominent physiological insulin secretagogue [1] [2] [3] [4] [5] . Elevations in extracellular glucose within the pancreatic islet microenvironment activate a series of events that culminate in secretion of insulin from β-cells [1] [2] [3] [4] [5] [6] [7] [8] [9] . These events are initiated by the influx of glucose into β-cells through glucose-specific transporters [1] [2] [3] [4] [5] . Elevated intracellular glucose is converted into intracellular ATP, thereby augmenting the ATP/ADP ratio. ADP bound to the K + ATP channel maintains the membrane potential in a hyperpolarized state [1] [2] [3] [4] [5] . However, when the metabolism of the β-cell is accelerated, ATP displaces ADP from the K + ATP channel [1] [2] [3] [4] [5] . As a result, this ATP-regulated channel is silenced, leading to depolarization of the membrane potential [1] [2] [3] [4] [5] . This depolarization opens voltage-dependent calcium (Ca 2+ ) channels that facilitate Ca 2+ entry from the extracellular environment [1] [2] [3] [4] [5] . Ca 2+ entry triggered by this glucose-and voltage-dependent mechanism activates the insulin exocytotic pathway [1] [2] [3] [4] [5] . Fusion of insulin vesicles with the β-cell plasma membrane leads to the release of the vesicular contents−insulin, ATP, and zinc-into the microenvironment of the islet of Langerhans [1] [2] [3] [4] [5] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
Numerous studies have confirmed that ATP and zinc are secreted from β-cells of islets in response to glucose and other stimuli [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Furthermore, these studies have definitively shown that zinc is co-packaged and co-secreted with insulin [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . However, it remains unclear whether the secreted ATP or zinc is derived solely from insulin secretory granules or if it emerges from secondary populations of vesicles and/ or independent cellular pools of ATP and zinc [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . In fact, studies conducted in multiple cell models and tissues have demonstrated that ATP is released physiologically via several pathways, including exocytosis from presynaptic terminals and diffusion through nucleotide transporters, anion channels, and large transmembrane pores (e.g., connexin hemi-channels and anion channels) [22, 23] . Regardless of the mode of ATP secretion into the islet microenvironment, extracellular ATP functions as a signaling molecule that evokes increases in insulin secretion by stimulating the influx of Ca 2+ through P2 purinergic receptors located in the plasma membrane of β-cells [22] [23] [24] [25] [26] [27] [28] [29] . P2 purinergic receptors are the sensors and intracellular transducers of extracellular purinergic signals [22] [23] [24] [25] [26] [27] [28] [29] . This family of ATP-sensing membrane receptors functions physiologically to mobilize cytoplasmic Ca 2+ and induce phospholipase C-mediated phospholipid turnover [22] [23] [24] [25] [26] [27] [28] [29] . Furthermore, P2 receptors are subdivided into two classes: ATP-sensing G protein-coupled receptors (P2Y receptors) or ATP-gated cation channels (P2X receptor channels or P2XR channels or P2XRs), based on differences in molecular structure and signal transduction mechanisms [22] [23] [24] [25] [26] [27] [28] [29] . Within the islet microenvironment, extracellular purinergic signaling molecules (nucleotides and nucleosides) have been postulated to have autocrine and paracrine functions [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Furthermore, numerous studies have demonstrated that purinergic molecules influence islet functions such as vascular tone and hormone secretion [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Specifically, these studies revealed that the activation of β-cell purinergic signaling cascades by exogenously applied ATP stimulated insulin secretion [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] .
There are numerous immunohistochemical and pharmacological studies confirming the expression of P2Y purinergic receptor subtypes in islets and β-cells [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . However, there is no complete molecular and biochemical characterization detailing the subtypes of P2XR channels expressed by pancreatic islets and β-cells. Furthermore, only a handful of studies suggest that P2XRs are expressed on pancreatic islet cells [38] [39] [40] . In studies performed on streptozocin-treated islets, the authors concluded that P2X 7 , an active player in apoptosis [41] , was expressed by infiltrating neutrophils and on α-cells within islets [39, 40] . Another study provides pharmacological evidence of the expression of P2XR channels by pancreatic β-cells [38] . Notably, the activity of P2XR channels is modulated by extracellular divalent metals, such as zinc and cooper [42] [43] [44] . This fact is critical to our examination of ATP and zinc as autocrine extracellular signaling molecules and to the intriguing mixture of P2XR channel subtypes found. All expressed P2XR subtypes found in the study herein are opened (gated) by both ATP and zinc.
We believe that ATP and zinc are autocrine and paracrine factors that are secreted within the pancreatic islet microenvironment. Furthermore, we suspect that these extracellular signaling molecules have profound regulatory impact upon insulin secretion. We speculate that we have unveiled an underlying autocrine purinergic signaling loop that may govern minute-by-minute regulation of insulin secretion that is independent of a glucose stimulus. We also believe that this autocrine purinergic signaling loop may synergize with the glucose-and voltage-dependent insulin secretion pathway to fully stimulate insulin secretory granule exocytosis. Taken together, we conclude that P2XR channels govern insulin secretion triggered by the autocrine and paracrine coligands ATP and zinc, two ligands that potentiate glucosestimulated insulin secretion by an autocrine mechanism.
Materials and methods
Rodent β-cell line culture INS-1 cells, clone 832/13, [45] and βTC3 cells [46] were generous gifts from Dr. Christopher Newgard (Duke University) and Drs. Manju Surana and Norman Fleischer (Albert Einstein College of Medicine), respectively. These rodent insulinoma cell lines were grown in T-150 tissue culture flasks at 37°C and 5% CO 2 in a humidified atmosphere. The β-cells were passaged every 5 days using 0.05% trypsin-EDTA. The complete culture medium was RPMI-1640 (Sigma; St. Louis, MO) supplemented with 5 mmol/l D-glucose, 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mmol/l HEPES, 2 mmol/l L-glutamine, 1 mmol/l sodium pyruvate, and 50 μmol/l β-mercaptoethanol.
Rat primary islets of Langerhans isolation and culture
Islets of Langerhans were isolated from male Lewis rats in the Department of Surgery [47] . Briefly, a midline abdominal incision was made; the bile duct was cannulated and injected with cold rodent Liberase (Roche Diagnostics). Thereafter, pancreatic islets were isolated and purified using a standard liberase-based digestion method combined with a Ficoll gradient separation method. An aliquot of islets was counted as "islet equivalents" (IEQ) under a scaled microscope with the use of diphenylthiocarbazone (Sigma; St. Louis, MO) staining. One IEQ was the islet tissue mass equivalent to a spherical islet of 150 μm in diameter.
Additionally, purity was assessed by comparing the relative quantity of dithizone-stained (Sigma; St. Louis, MO) endocrine tissue with unstained exocrine tissue. Islet viability was assessed following staining with acridine orange (100 μg/ml) and ethidium bromide (100 μg/ml) and subjected to two-color fluorescence microscopy. Only islet isolations with >90% viability and >85% purity were used.
Islets were provided to our cell physiology laboratory unattached in a T-150 tissue culture flask. After isolation, islets were cultured in complete Miami Medium 1A (Cellgro/Mediatech; Herndon, VA) supplemented with Lglutamine, 100 U/ml of penicillin, 100 mg/ml of streptomycin, and 10% fetal bovine serum at 26°C and 5% CO 2 . One day after isolation, 200 IEQs were dispersed into 35-mm tissue culture dishes and then cultured at 37°C and 5% CO 2 in a humidified atmosphere until they attached to the tissue culture dish.
Novel co-secretion bioassay for secreted ATP, zinc, and insulin from rat islets Insulin, ATP, and zinc secretion was assayed in HBSS. Islets grown in 35-mm tissue culture dishes were washed in HBSS followed by an overnight pre-incubation in the same buffer at 37°C and 5% CO 2 in a humidified atmosphere. At the time of the experiment, islets were placed on a 37°C slide warmer and washed in HBSS. After stimulating islets with 10 mmol/l glucose, samples of the supernatant were collected at appropriate timepoints (0, 5, 15, 30, and 45 s, and 1, 3, 5, and 30 min). These supernatant samples were separated into three parts, and secreted insulin was measured with a rat/mouse insulin ELISA kit (Millipore/ Linco; St. Louis, MO), secreted zinc was detected with a Zinquin fluorescence indicator (Sigma; St. Louis, MO) and secreted ATP was analyzed by mixing with luciferinluciferase detection reagent (Sigma; St. Louis, MO) [48] . Data are expressed as fold increase of post-stimulation response versus pre-stimulation.
For later experiments focusing on extracellular ATP and zinc signaling effects on insulin secretion, exogenous ATP (500 nmol/l) and/or zinc (20 μmol/l) were added in lieu of glucose as the stimulus and secreted insulin was assessed at 0, 5, 15, 30, and 45 s, and 1, 3, and 5 min via ELISA. In other experiments, glucose was the stimulus in the absence and presence of an ATP scavenger, zinc chelator, and P2 receptor antagonists.
Degenerate and specific RT-PCR to identify P2XR mRNA subtype expression in rodent primary islets and β-cell models Total RNA was isolated from cells using PureLink Micro-toMidi-Total RNA Purification System (Invitrogen; Carlsbad, CA). One microgram of total RNA was reverse transcribed to synthesize cDNA using iScript cDNA Synthesis Kit (BioRad; Hercules, CA). The degenerate primers used for amplifying P2X 1 -P2X 5 and P2X 7 [49] were primer A: 5′-TTCACCMTYYTCATCAARAACAG CATC-3′ and primer B: 5′-TGGCAAAYCTGAAGTTG WAGCC-3′.
The reaction was run at a 52°C annealing temperature; this reaction generates a 330 base pair (bp) degenerate P2XR PCR product as a single band that contains multiple P2XR subtype sequences and spans multiple introns to insure that the product is not derived from genomic DNA.
The specific primers for amplifying P2X 6 [50] were primer A: 5′-GCTCAGGCCAAGAACTTCAC-3′ and primer B: 5′-AAACCGGCCTCTCTATCCAC-3′.
The reaction was run at a 57.8°C annealing temperature; this reaction yields a specific P2X 6 PCR product of 533 bp. The length of the PCR products was quantified by agarose gel electrophoresis and visualized by staining with ethidium bromide versus a 100-bp ladder.
Degenerate P2XR PCR products were gel-extracted and purified using a QIAquick gel extraction kit (Qiagen; Valencia, CA). The degenerate P2XR PCR products were ligated into the pGEM-T vector system (Promega; Madison, WI). Ligated P2XR PCR products were transformed into JM109 competent cells (Promega; Madison, WI). The transformed JM109 cells were plated on LB-agar plates containing ampicillin (100 μg/ml), 5-bromo-4-chloro-3-indolyl β-D-galactopyranoside (40 μg/ml), and isopropylthiogalactoside (100 μg/ml). White colonies were selected and cultured in LB medium containing ampicillin (100 μg/ml). Plasmids were isolated from selected JM109 cells using Perfectprep Plasmid Mini Kit (Eppendorf; Westbury, NY). Purified degenerate P2XR PCR product inserts were sequenced by a DNA sequencing core at the University of Alabama at Birmingham.
Western blot analysis to identify P2XR protein subtypes in rodent primary islets and β-cell models Pancreatic islets and β-cell lines were lysed in a RIPA buffer containing 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 50 mM pH 8.0 Tris-Cl, and a complete miniprotease inhibitor cocktail tablet (Roche Diagnostics; Mannheim, Germany). Proteins were loaded and run on a 4-12% Bis-Tris SDS-polyacrylamide gel (Invitrogen; Carlsbad, CA) and transferred to a polyvinylidene difluoride (PVDF) membrane (Bio Rad; Hercules, CA). Immunoblotting was performed with rabbit polyclonal antibodies against P2X 2 , P2X 3 , P2X 4 , and P2X 6 receptors (Alomone Labs; Jerusalem, Israel) [49] [50] [51] [52] . Reactivity was detected by horseradish peroxidase-labeled goat anti-rabbit secondary antibody (New England Biolabs; Ipswich, MA). Enhanced chemiluminescence was used to visualize the secondary antibody.
Immunofluorescence histochemistry to identify P2XR subtype expression in β-cells of islets of Langerhans of rats
Rat pancreatic tissues were fixed with 4% para-formaldehyde. Blocked tissue sections (5% BSA) were incubated in mouse monoclonal insulin antibody (1:100; Lab Vision; Fremont, CA) for 30 min. After washing, Alexa Fluor 488 goat antimouse IgG (1:100; Molecular Probes; Eugene, OK) was applied for 30 min. Sections were blocked again for 30 min and then incubated in rabbit polyclonal P2XR antibody (1:500; Alomone Labs; Jerusalem, Israel) [28] for 30 min. After washing, Alexa Fluor 594 goat anti-rabbit IgG (1:100; Molecular Probes; Eugene, OK) was applied for 30 min followed by 4,6-diamidino-2-phenylindole (DAPI; Invitrogen; Carlsbad, CA) for nuclear staining. Images were captured with an inverted Olympus IX70 microscope.
Rat/mouse insulin ELISA assay for secreted insulin Insulin concentrations were determined from collected supernatant aliquots or samples from co-secretion bioassays by rat/mouse insulin ELISA (Linco Research; St. Charles, MO), according to the manufacturer's protocol with no modifications.
Zinquin fluorescence assay for secreted zinc An aliquot of the collected supernatant from co-secretion bioassays was mixed with Zinquin reagent (Sigma; St.
Louis, MO) in a 96-well plate. After which, the plate was loaded into a fluorometer plate reader. Fluorescence was recorded at an excitation wavelength of 358 nm and emission wavelength of 497 nm. Data are expressed as fold increase of post-stimulation response versus pre-stimulation.
Luciferase-luciferin bioluminescence assay for secreted ATP An aliquot of collected supernatant from co-secretion bioassays was mixed with lyophilized luciferase-luciferin reagent (Sigma; St. Louis, MO) in a cuvette. After which, the reaction was placed in a Turner TD 20/20 luminometer. Bioluminescence was recorded after a 15-s photon collection interval. Data are expressed as fold increase of poststimulation response versus pre-stimulation.
Statistics
Results are expressed as means ± standard error of the mean (SEM). Statistics were performed using the software program Column Descriptive Statistics. Statistical significance was evaluated by t-test. P value of <0.05 was considered significant.
Materials
Analytical grade reagents and deionized water were used. Dglucose, adenosine 5′ triphosphate, zinc chloride, HEPES, diphenylthiocarbazone, dithizone pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate, diethylene triamine pentaacetic acid, apyrase, suramin, and bovine serum albumin were obtained from Sigma (St. Louis, MO). Sodium chloride, potassium chloride, potassium monophosphate, magnesium sulfate, calcium chloride, β-mercapoethanol, and sodium bicarbonate were purchased from Fisher Scientific. Fetal bovine serum, penicillin, streptomycin, L-glutamine, and sodium pyruvate were acquired from Invitrogen (Carlsbad, CA). All other sources for reagents, chemicals, drugs, or cell culture medium are identified above.
Results
Purinergic-signaling molecules ATP and zinc are secreted from isolated rat islets into the extracellular environment in response to the insulin secretagogue glucose To address the hypothesis, the extracellular secretion of the purinergic-signaling molecules ATP and zinc was examined in parallel with insulin secretion. ATP and zinc were secreted from primary rat islets into the extracellular environment in response to the insulin secretagogue glucose (Fig. 1) . Increasing the extracellular glucose concentration to 10 from 3 mmol/L elicited the immediate (0-60 s) secretion of insulin, ATP, and zinc (Fig. 1a-c) . During this immediate phase of secretion, extracellular zinc peaked (6.6±0.35 fold) and then declined (3.2±1.3 fold), while insulin and ATP continued to accumulate (Fig. 1d) . Between 180 and 300 s, extracellular insulin reached a steady state, but extracellular ATP and zinc declined (Fig. 1d) . At later time points, all three molecules were increased at 1,800 s. During this phase of secretion, extracellular zinc increased to 1.8±0.77 fold (Fig. 1c) , insulin peaked at 9.5±0.69 fold (Fig. 1a) and ATP peaked at 6.4±0.65 fold (Fig. 1b) . Taken together, these results demonstrate that the physiological insulin secretagogue glucose stimulates the extracellular secretion of the purinergic-signaling molecules ATP and zinc. Similar results with regard to insulin versus ATP secretion and insulin versus zinc have been described previously [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ; however, we contend that a "real-time" examination of secretion of these three critical mediators has not been assessed simultaneously in the literature.
Extracellular purinergic signaling molecules participate in glucose-stimulated insulin secretion (GSIS) from isolated rat islets Initially, exogenous ATP and zinc were tested for their potency as insulin secretagogues in rat islets grown in primary culture. Results revealed that these molecules stimulated insulin secretion from primary rat islets (Fig. 2). Figure 2a shows that the insulin stimulatory effect of exogenous ATP was initially observed between 30 and 60 s. ATP-induced extracellular insulin peaked at 180 s to 12.7±2.2 fold. Thereafter, extracellular insulin declined (4.3±0.3 fold at 300 s) but remained elevated compared to baseline. Additionally, immediate and potentiated insulin secretion (5-60 s) was observed in response to the administration of exogenous ATP and glucose. ATP and glucose-induced extracellular insulin peaked to 8.8±0.3 fold at 60 s; after which, extracellular insulin declined to 4.7±0.5 fold over baseline. Figure 2b reveals that the application of exogenous zinc evoked insulin secretion. The zinc-induced increase in extracellular insulin was detected between 30 and 60 s and peaked to 3.7±1.7 fold above baseline. Furthermore, zinc together with glucose stimulated an increase in extracellular insulin that began between 30 and 60 s and peaked at 300 s to 7.3±1.9 fold. Since both P2XR channel ligands are secreted together, the collective effects of ATP and zinc on insulin secretion was also assessed. Figure 2c shows that ATP and zinc stimulated an increase in extracellular insulin that peaked initially to 7.9± 1.9 fold at 15 s. After a decline (15-60 s), extracellular insulin peaked again at 180 s to 8.3±1.6 fold over baseline. The results also reveal that ATP, zinc, and glucose induced immediate and potentiated insulin secretion (5-15 s). Extracellular insulin peaked to 12.4±0.4 fold at 60 s and then declined to 5.6±0.8 fold at 300 s. Figure 2d shows the rank order of potency of the insulin secretagogue stimuli used in these studies: ringer (343) < zinc (957) < glucose + zinc (1,475) < ATP + zinc (1,691) ≤ glucose (1,780) < Fig. 1 The insulin secretagogue glucose stimulates the extracellular secretion of insulin, ATP, and zinc. Isolated rat primary islets were grown in adherent culture and were stimulated with 10 mmol/l glucose. Samples of the supernatant were collected at fixed time points, divided into three parts, and subsequently analyzed for the presence of secreted insulin, ATP, and zinc via rat/mouse insulin ELISA, luciferase-luciferin bioluminescence, and zinquin fluorescence, respectively. The results show that glucose stimulation elicited insulin, ATP, and zinc secretion. Values represent the means±SE of three to five experiments. *P<0.05 vs. pre-stimulation for all time points glucose + ATP (1,992) ≤ glucose + ATP + zinc (2,202) ≤ ATP (2,226). The results show that ATP and zinc are potent insulin secretagogues. However, ATP proved to be the most potent insulin secretagogue even over the physiological insulin secretagogue glucose. Additionally, ATP in conjunction with glucose did not display an additive or synergistic effect, thereby suggesting that these molecules function within the same insulin secretory pathway. Nonetheless, these findings suggest that extracellular purinergic signaling molecules stimulate insulin secretion from isolated rat islets.
To investigate a possible autocrine role for extracellular secreted purinergic signaling molecules in governing islet function, GSIS was evaluated in the presence of the extracellular ATP/ADP phosphatase apyrase and the zinc chelator DTPA. Figure 3 shows that glucose stimulated a 9.5±0.69 fold increase in insulin secretion over basal secretion. However, in the presence of the extracellular ATP-and ADP-scavenging enzyme apyrase, GSIS was attenuated markedly from 9.5±0.69 fold to 1.6±0.4 to 2.2± 0.14 fold. Additionally, GSIS was lowered to 1.6±0.4 to 3.6±0.5 fold from 9.5±0.69 fold in the presence of the extracellular zinc chelator DTPA. In the presence of both Secreted ATP and zinc participate in insulin secretion from isolated rat islets. Glucose-stimulated insulin secretion in isolated rat islets was examined in the presence of an extracellular ATP scavenger (apyrase) and/or a zinc chelator (DTPA). The results show that the insulin secretory effects of glucose were attenuated in the presence of apyrase and DTPA. Values represent the means ± SE of 3-11 experiments. *P<0.05 vs. glucose-stimulated insulin secretion response. Controls with apyrase alone and DTPA alone were without effect in the absence of glucose (data not shown) apyrase and DTPA, GSIS was also reduced but not eliminated fully (5.5±1.3 to 5.7±1.5 fold). It appeared from the results that apyrase and DTPA might be hampering each other's inhibitory effect when added together in our experiments. The reasons for this are unclear. These results demonstrate that blocking endogenous extracellular ATP and zinc signaling attenuated GSIS. Taken together, these findings support the hypothesis that ATP and zinc are extracellular autocrine purinergic signaling molecules that participate in and potentiate physiological induction of insulin secretion by glucose.
Multiple ATP-gated and zinc-modulated P2X purinergic receptor channels are expressed by β-cells and primary islets
To test the hypothesis that P2XR channels may mediate extracellular ATP and zinc's insulin secretagogue function, molecular, biochemical, and immunohistochemical studies were performed to investigate P2XR channel expression by normal primary pancreatic islet cultures and immortalized β-cell lines. As a first approach, RT-PCR was performed to detect mRNA expression of the P2XR channel subtypes in primary rat islets and in β-cell models from rat and mouse (INS-1 and βTC3, respectively). Figure 4 reveals that these insulin-secreting primary and immortalized model systems express mRNA for multiple P2XR channel subtypes. A degenerate P2XR PCR product of expected size, 330 bp, was amplified in primary rat islet cDNA samples and in the rat and mouse β-cell models (Fig. 4a) . Sequencing of these degenerate P2XR PCR products revealed mRNA expression of P2X 2 , P2X 3 , and P2X 4 subtypes in islets, INS-1, and βTC3 (see table within Fig. 4a ). The only sequence that is not amplified by these degenerate PCR primers is P2X 6 [49] [50] [51] [52] . As such, specific primers for P2X 6 were designed. Results from RT-PCR analysis revealed that P2X 6 primers amplified a PCR product of the expected size, 533 bp (Fig. 4b) [50] . A single band was observed from islet cDNA, while two bands were detected in INS-1 and βTC3 β-cells. DNA sequencing confirmed that the larger band was P2X6 and that the smaller amplicon in cell lines was a splice variant that is likely generated due to immortalization (data not shown). PCR products were not observed in the cDNA negative controls (Fig. 4) . Taken together, these data suggested that P2X 2 , P2X 3 , P2X 4 , and P2X 6 are expressed within islets and β-cells.
Western blot analysis using subtype-specific antibodies was performed to confirm the expression of the same P2XR channel subtypes at the protein level. Figure 5 shows representative immunoblots that confirm that multiple P2XR channel subtypes are expressed by primary islets and β-cell models derived from rodent endocrine pancreas. In all insulin-secreting model systems, two immunoreactive protein bands of ∼58 kD (unprocessed precursor isoform) and ∼64 kD (glycosylated isoform) were detected for P2X 2 (Fig. 5a ). The P2X 3 antibody detected a ∼64-kD protein band (glycosylated isoform) in primary islets and both β-cell models (Fig. 5b) . As shown in Fig. 5c The results also show that a specific P2X 6 PCR product of the expected size, 550 bp, was detected in all insulin-secreting model systems. Additionally, a ∼450-bp P2X 6 PCR product was unexpectedly detected, and we suspect it to be a splice variant (unprocessed precursor) and ∼60-kD (glycosylated isoform) immunoreactive bands were expressed in all endocrine pancreatic model systems when using the P2X 4 antibody to immunoblot. Two immunoreactive isoforms of ∼48 kD (unprocessed precursor) and ∼68 kD (glycosylated isoform) were detected in primary islets and both β-cell models when using the P2X 6 antibody to immunoblot (Fig. 5d ). In the presence of respective blocking P2XR subtype peptides, antibodies for P2X 2 , P2X 3 , P2X 4 , and P2X 6 did not detect protein (data not shown). Taken together, RT-PCR and Western blot analysis provide molecular and biochemical evidence to support the hypothesis that multiple P2XR channels, specifically P2X 2 , P2X 3 , P2X 4 , and P2X 6 , are expressed by β-cell lines and primary islets in vitro.
To ascertain whether β-cells, within islets of Langerhans, expressed P2XR channel subtypes, insulin (red) and P2XR channel (green) double-labeling immunofluorescence was performed on rat pancreatic tissue sections. Figure 6 demonstrates that pancreatic β-cells within islets of Langerhans express multiple ATP-gated and zincmodulated P2XR channels. Results revealed that the majority of cells located within the islet core were immunoreactive for the β-cell marker insulin. Additionally, P2X 2 (Fig. 6a), P2X 3 (Fig. 6b), P2X 4 (Fig. 6c) , and P2X 6 ( Fig. 6d ) channel subtypes were expressed by islets. Although more difficult to observe in the images because the plane of focus was set for the islet staining, acinar and duct cells of the pancreas were also positive for these P2XR channel subtypes as suggested from the other laboratories (Fig. 6) [24] . Figure 6 also revealed that insulin-positive cells within islets were immunoreactive for P2X 2 (Fig. 6a,  merge), P2X 3 (Fig. 6b, merge), P2X 4 (Fig. 6c, merge) , and P2X 6 (Fig. 6d, merge) subtypes. Similar results were obtained via immunostaining of isolated rat islets grown in attached primary culture (data not shown). These data demonstrate that pancreatic β-cells within islets of Langerhans express a unique subset of P2XR channels that are gated by extracellular ATP and modulated by extracellular zinc.
P2XR channels and P2Y G protein-coupled receptors participate in glucose-stimulated insulin secretion
To investigate a possible functional role for P2XR channels in β-cells, glucose-stimulated insulin secretion was evaluated in the presence of PPADS (P2XR antagonist) and suramin (P2XR and P2YR antagonist). Results demonstrate that P2XR channels participate in glucose-stimulated insulin secretion in isolated rat islets (Fig. 7) . Figure 7 shows that glucose stimulated a 9.5±0.69 fold increase in insulin secretion over basal secretion. However, in the presence of PPADS, GSIS was attenuated to between 6.6± 1.6 and 1.8±0.26 fold compared to 9.5±0.69 fold in the absence of the P2XR antagonist. Additionally, glucose only elicited between 4.9±1.7 and 1.1±0.08 fold increases in insulin secretion in the presence of suramin. The stronger inhibitory effect of suramin is likely due to antagonism of P2Y receptors as well as P2XRs. These results demonstrate that inhibition of P2XR channels and P2Y G proteincoupled receptors attenuates GSIS. This finding is consistent with the hypothesis that autocrine purinergic signaling by extracellular purinergic ligands, interacting with their specific P2 receptors, participates in and potentiates GSIS.
Discussion
Our results support the view that the interstitium surrounding islets may provide an ideal microenvironment for purinergic signaling. To be more specific, we demonstrate that all components of the P2XR channel signaling pathway are present within the islet microenvironment, namely (1) extracellular secretion of P2XR channel ligands, ATP and zinc; (2) autocrine extracellular ATP and zinc signaling; (3) presence of ATP-gated and zinc-modulated P2XR channel on the β-cell surface within islets, and (4) 
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Fig. 5 P2XR channels are expressed at the protein level in rodent primary islets and β-cell models. Western blot analysis was performed to confirm the mRNA-detected P2XR channel subtypes expressed by rat primary islets, INS-1, and βTC3. a The results show an unprocessed precursor isoform (∼58 kD) and a mature, glycosylated isoform (∼64 kD) of P2X 2 were detected in islets, INS-1, and βTC3. b A mature, glycosylated isoform (∼64 kD) of P2X 3 was detected in all insulin-secreting model systems. c Two mature, glycosylated isoforms (∼54 and ∼60 kD) of P2X 4 were detected in all insulin-secreting model systems. d The unprocessed precursor (∼48 kD) and a mature, glycosylated isoform (∼68 kD) of P2X 6 were detected in all insulinsecreting model systems channel involvement in glucose-driven insulin secretion. On the basis of these results, we propose that autocrine P2XR channel purinergic signaling may play a profound underlying role in glucose-stimulated insulin secretion. This model is proposed based upon our work and the work of other laboratories (Fig. 8) and is discussed below.
It is well established that insulin secretagogues induce the release of insulin, ATP, and zinc into the microenvironment of the islet of Langerhans [1] [2] [3] [4] [5] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Furthermore, studies have shown definitively that zinc is co-packaged and co-secreted with insulin [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . We postulate that the reduced amount of extracellular zinc compared to insulin detected in co-secretion assays is likely due to the uptake of this biometal by cells of the islets via zinc influx transporters (ZIPs) as a possible recycling mechanism [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . With regard to ATP, it remains unclear whether the secreted ATP is derived from insulin secretory granules, some secondary pool of vesicles, and/or independent cellular pools of ATP [22, 23] . Obermuller and co-workers have documented a difference between the timing of ATP and insulin secretion from β-cells [15] . This finding suggests a possible insulin vesicle-independent mechanism of ATP release. Furthermore, studies conducted in the central nervous system demonstrate that ATP can be released physiologically via several pathways, including exocytosis from neurotransmitter-containing vesicles and diffusion through nucleotide transporters, anion channels, and large transmembrane pores (e.g., connexin hemi-channels and anion channels) [22, 23] . We also speculate that the decline in ATP accumulation in our co-secretion assays is due to degradation by ecto-enzymes such as secreted or membrane-bound ATPases [22, 23] . It was interesting that there appeared to be an initial peak of zinc secretion that preceded that of insulin and ATP secretion. We speculate that there may also be efflux mechanisms for zinc and, possibly, ATP that may be independent of insulin secretion via exocytosis of insulin secretory granules. Taken together, our results confirm that ATP and zinc are secreted in a regulated manner into the islet microenvironment in parallel with insulin. Furthermore, our findings also hint at possible mechanisms by which extracellular purinergic signals are removed as well as the likely generation of adenosine in the islet microenvironment. To our knowledge, this report is the first to assess the co-release of insulin, zinc, and ATP over an extensive time course.
We provide new evidence on several levels that supports autocrine signaling roles for ATP and zinc in governing islet function in general and insulin secretion in particular.
Although studies have previously documented exogenous ATP's insulin secretagogue effects [32] [33] [34] [35] [36] [37] [38] , no studies have examined the effects of exogenous zinc alone or the collective effects of exogenous ATP and zinc on insulin secretion. Thus, to our knowledge, we show for the first time that exogenous zinc is an insulin secretagogue in the absence and presence of ATP. Our findings also suggest that ATP and zinc may function within the same regulatory pathway governing insulin secretion. The most critical aspect of our work shows that endogenously secreted ATP and zinc play an integral autocrine regulatory role in governing glucose-stimulated insulin secretion. We postulated that the parallel secretion of ATP and zinc may trigger Ca 2+ entry via P2XR channels to amplify the Ca 2+ signal driven by voltage-activated Ca 2+ entry channels (VDCCs) to trigger insulin secretion. This effect is not unlike the cotransmitter activity of ATP at glutamate-driven-and other stimulatory neurotransmitter-postsynaptic membranes to amplify the signal and trigger a more robust postsynaptic signal [53] . Taken together, these data suggest that autocrine ATP and zinc may collaborate to convey an underlying stimulatory signal within the "classical" glucose-stimulated insulin stimulus-secretion pathway.
We provide novel results examining the expression of P2XR channels on normal primary islets and immortalized β-cell lines. Molecular and biochemical examination of the P2XR channel subtypes reveal that multiple ATP-gated and zinc-modulated P2XR channels are expressed by β-cells in vitro and in vivo, namely P2X 2 , P2X 3 , P2X 4 , and P2X 6 . In our P2X 6 RT-PCR studies, we speculate that the smaller band, ∼450 bp, is a P2X 6 splice variant that has been reported in other cell systems [54] . We did not detect a Fig. 8 Proposed model for an underlying P2XR-channel purinergic signaling loop within the glucose-stimulated insulin secretion coupling pathway. An increase in the extracellular glucose concentration leads to a series of events that result in the secretion of ATP and zinc into the islet microenvironment. Extracellular ATP and zinc bind to and activate a specific subtype of P2XR channels expressed by β-cells. The stimulation of these ATP-gated and zinc-modulated P2XR channels activates calcium influx from extracellular stores that synergizes with voltage-dependent calcium channeldriven calcium influx to enhance glucose-stimulated insulin secretion different sized protein that correlates with this splice variant via immunoblotting. Alternative splicing has been described previously for P2X 1 , P2X 2 , P2X 4 , and P2X 5 [55] [56] [57] [58] [59] . In regard to P2XR channel protein, all P2XR channel subtypes have multiple N-linked glycosylation sites [26, 28, 29] . We speculate that the detected P2XR channel protein bands with higher molecular weights represent the glycosylated forms of the proteins as we have demonstrated previously [49] . In support of our findings, previous pharmacological studies suggested that P2XR channels are expressed by β-cells [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Importantly, the particular P2XR channel subtypes found can heteromultimerize [60] . There is evidence in the literature for P2X 2 /P2X 3 , P2X 2 / P2X 6 , and P2X 4 /P2X 6 heteromultimers. P2X 6 expressed alone only confers functional Ca 2+ -permeable, non-selective cation currents upon complex glycosylation. More notably, P2X 6 modulates the activity and the trafficking of other P2XR channels, most notably P2X 2 and P2X 4 . Thus, we provide both molecular and biochemical evidence that demonstrates that a unique subset of P2XR channel subtypes, which are gated by extracellular ATP and positively modulated by extracellular zinc, are expressed by β-cells within islets in vitro and in vivo.
In closing, this work uncovers important roles for autocrine extracellular ATP and zinc signaling in the islet microenvironment via an intriguing subset of "fast-acting" P2X receptor Ca 2+ entry channels expressed on normal β-cells within islets. We hypothesize that this purinergic signaling loop may normally underlie and/or amplify the glucose-driven stimulus-secretion coupling mechanism. Furthermore, we postulate similarly that extracellular ATP and zinc may also modulate insulin secretion on a minute-by-minute basis in the absence of the glucose stimulus. Finally, we propose that this subset of P2XR channels expressed on the β-cell surface may be therapeutic targets to augment and/or rescue insulin secretion in a glucose-and voltage-independent manner. Any approach to augment insulin secretion in an impaired, damaged, or transplanted β-cell or islet or in an implanted stem cell programmed to differentiate into an islet or β-cell would be welcomed to help control the multiple forms of diabetes mellitus.
